RAWGIT 40 MG (ESOMEPRAZOLE) – HARD GELATIN CAPSULES

Active Ingredient: Esomeprazole 40 mg
Pharmaceutical Form: Hard gelatin capsules containing enteric-coated pellets
Pack Size: 14 capsules
Therapeutic Class: Proton Pump Inhibitor (PPI) – Gastric Acid Secretion Inhibitor.

Product Overview

Rawgit 40 mg contains esomeprazole, a proton pump inhibitor used to reduce gastric acid production. It is commonly prescribed for acid-related gastrointestinal disorders, including gastroesophageal reflux disease (GERD), erosive esophagitis, and peptic ulcer disease.

Esomeprazole works by selectively inhibiting the gastric proton pump (H⁺/K⁺-ATPase) in the stomach's parietal cells, thereby reducing the amount of acid secreted into the stomach.

The enteric-coated pellets protect the active ingredient from degradation by stomach acid, allowing esomeprazole to be released and absorbed in the intestine.

Indications and Uses

Rawgit 40 mg may be prescribed for:

• Gastroesophageal Reflux Disease (GERD): Helps relieve acid reflux symptoms, including heartburn and acid regurgitation.
• Erosive Esophagitis: Promotes healing of inflammation and damage to the esophageal lining caused by stomach acid.
• Maintenance of Healing of Erosive Esophagitis: Helps prevent recurrence of acid-related esophageal damage.
• Peptic Ulcer Disease: Used as part of appropriate treatment regimens for gastric and duodenal ulcers.
• Helicobacter pylori Eradication: Used in combination with appropriate antibiotics to eliminate H. pylori infection and reduce the risk of associated peptic ulcers.
• NSAID-Associated Ulcers: Helps reduce the risk of gastric ulcers in selected patients taking nonsteroidal anti-inflammatory drugs (NSAIDs).
• Zollinger–Ellison Syndrome: Helps control excessive gastric acid secretion associated with this condition.

Important: The appropriate strength and treatment duration depend on the specific indication and the patient's clinical condition.

Mechanism of Action

Esomeprazole selectively inhibits the gastric proton pump (H⁺/K⁺-ATPase), which is responsible for the final step of gastric acid secretion in stomach parietal cells.

Its actions include:

• Reducing basal and stimulated gastric acid secretion.
• Increasing gastric pH (reducing stomach acidity).
• Promoting healing of acid-related damage to the esophageal and gastric lining.
• Helping relieve heartburn and acid reflux symptoms.
• Supporting ulcer healing when used as part of an appropriate treatment regimen.

Dosage and Administration

Route of Administration: Oral.

The appropriate dose and treatment duration depend on the indication and the patient's clinical condition.

Common adult dosing regimens include:

• GERD with erosive esophagitis: 20–40 mg once daily for 4–8 weeks.
• Symptomatic GERD: Usually 20 mg once daily for 4 weeks, with further treatment if clinically indicated.
• Maintenance of erosive esophagitis healing: Usually 20 mg once daily.
• NSAID-associated gastric ulcer prevention: 20–40 mg once daily in selected patients.
• H. pylori eradication: Used with appropriate antibiotics according to the prescribed combination regimen.
• Zollinger–Ellison syndrome: Usually 40 mg twice daily initially, with dosage adjusted according to clinical response.

Administration Instructions:

• Take preferably at least one hour before meals.
• Swallow the capsule whole with water.
• Do not crush or chew the enteric-coated pellets.
• If swallowing is difficult, the capsule may be opened and its intact pellets mixed with applesauce, provided this method is permitted by the product leaflet.
• Take the medication regularly as prescribed.

Important: Rawgit 40 mg is not the appropriate dose for every acid-related condition. The 40 mg strength should be used according to the physician's prescription and the specific indication.

Possible Side Effects

Common side effects may include:

• Headache.
• Abdominal pain.
• Nausea and vomiting.
• Diarrhea.
• Constipation.
• Flatulence (excessive gas).
• Dry mouth.

Less common or potentially serious adverse reactions include:

• Allergic reactions, including skin rash and swelling.
• Acute interstitial nephritis (kidney inflammation).
• Severe or persistent diarrhea associated with intestinal infections.
• Low magnesium levels, particularly with prolonged use.
• Vitamin B12 deficiency with long-term use.
• Increased risk of bone fractures with prolonged, high-dose therapy in certain patients.
• Severe skin reactions.

Seek medical attention if severe or unusual symptoms develop.

Contraindications and Precautions

Contraindications:

• Known hypersensitivity to esomeprazole, substituted benzimidazoles, or any product component.
• Concomitant use with rilpivirine-containing products.

Precautions:

• Patients with severe liver impairment may require dosage adjustment.
• Inform the doctor about any history of liver or kidney problems.
• Long-term treatment should be periodically reviewed by a healthcare professional.
• Prolonged use may contribute to low magnesium or vitamin B12 levels.
• Patients at risk of osteoporosis or fractures should discuss long-term PPI use with their doctor.
• Esomeprazole may mask symptoms of certain serious gastric conditions, including gastric malignancy.
• Use during pregnancy or breastfeeding should be discussed with a healthcare professional.

Important Drug and Lifestyle Interactions

• Clopidogrel: Esomeprazole may reduce the antiplatelet effect of clopidogrel; concomitant use is generally not recommended.
• Warfarin: May increase INR and bleeding risk; monitoring may be required.
• Methotrexate: May increase methotrexate exposure, particularly with high-dose treatment.
• Digoxin: May increase digoxin absorption and blood concentrations.
• Tacrolimus: May increase tacrolimus concentrations; monitoring may be necessary.
• Certain HIV medications: Esomeprazole can interact with some antiretroviral drugs, including rilpivirine and atazanavir.
• Iron supplements: Reduced stomach acidity may affect the absorption of certain iron preparations.

Inform your healthcare professional about all medications and supplements you are taking.

Storage Conditions

• Store at room temperature according to the manufacturer's instructions.
• Protect from excessive heat and moisture.
• Keep the capsules in their original packaging.
• Keep the container tightly closed, if applicable.
• Keep out of reach of children.
• Do not use after the expiry date.

Patient Counseling Points

• Take Rawgit preferably one hour before meals.
• Swallow the capsule without crushing or chewing the enteric-coated pellets.
• Take the medication consistently as prescribed.
• Do not increase the dose or extend treatment without medical advice.
• Avoid excessive consumption of foods and beverages that trigger heartburn or acid reflux.
• Seek medical evaluation if symptoms persist despite treatment.
• Report difficulty swallowing, unexplained weight loss, persistent vomiting, vomiting blood, or black stools promptly.
• Long-term treatment should be reviewed periodically to ensure continued medical necessity.

Medical References

1. U.S. Food and Drug Administration (FDA): Nexium (Esomeprazole Magnesium) – Prescribing Information. View FDA prescribing information.
2. National Library of Medicine (DailyMed): Esomeprazole Magnesium Delayed-Release Capsules – Drug Information. View prescribing information.
3. MedlinePlus – U.S. National Library of Medicine: Esomeprazole Drug Information. Read patient information.
4. National Health Service (NHS): About Esomeprazole – Uses and Clinical Information. Read medical information.
5. National Health Service (NHS): Esomeprazole Side Effects and Safety Information. Read safety information.

Patient Disclaimer: This information is intended for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using this medication. The appropriate dosage and duration depend on the patient's medical condition, treatment response, and individual risk factors. Long-term use should be monitored by a healthcare professional.